TrialBJOG : an international journal of obstetrics and gynaecology2022

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo-controlled superiority study (VANISH 306).

R Sobel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.